Novel topical allogeneic bone-marrow-derived mesenchymal stem cell treatment of hard-to-heal diabetic foot ulcers: a proof of concept study

Table 1 Participant characteristics

	Age (years)	Diabetes type	Diabetes duration (years)	BMI (kg/m²)	Smoker^a	Alcohol abuse	Sys. blood pressure (mmHg)	HbA1c^b (mmol/ml)	eGFR (ml/min)	UACR (mg/g)	LDL (mmol/l)
Participant 01	70	T2DM	12	23.9	No	No	150	57	83	27	1.8
Participant 02	68	T2DM	6	29.0	Ex	No	108	93	99	20	0.3

BMI, Body Mass Index; Sys, Systolic; HbA1C, Glycated hemoglobin; eGFR, estimated Glomerular Filtration Rate; UACR, Urine-Albumin-Creatinin-Ratio; LDL. Low density Lipoprotein; T2DM, Type II Diabetes; Mellitus; Ex, Former
^aDivided in Yes(active) No (never smoked) Ex. (prior smoker > 5 years tobacco free)
^bHbA1c is presented according to National Glycohemoglobin Standardization Program

ISSN: 1757-6512